← Back to Search

Emollient

Control group (no moisturizers) for Atopic Dermatitis (BEEP Trial)

N/A
Waitlist Available
Led By Eric L. Simpson, M.D., M.C.R.
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

BEEP Trial Summary

The purpose of this protocol is to determine the feasibility of doing larger follow-up studies examining whether emollients used from birth can prevent eczema in high-risk babies and to help investigators find out if emollients (moisturizing skin creams) used from birth can prevent eczema in high-risk babies. Hypothesis: Enhancing the skin barrier from birth using emollients will prevent or delay the onset of eczema, especially in predisposed infants.

BEEP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of families willing to be randomized.
Secondary outcome measures
Age at onset of eczema
Amount of contamination as a result of increased awareness in the control group
Filaggrin mutation status
+7 more

BEEP Trial Design

2Treatment groups
Active Control
Group I: Control group (no moisturizers)Active Control1 Intervention
This group will be asked NOT to use any skin moisturizers and use only soap substitutes on their infants.
Group II: Intervention (moisturizer group)Active Control3 Interventions
One group will be instructed to use a choice of 3 FDA-approved moisturizers and soap substitutes on their newborn infants.

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
975 Previous Clinical Trials
7,386,166 Total Patients Enrolled
Eric L. Simpson, M.D., M.C.R.Principal InvestigatorOregon Health and Science University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby May 2025